|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.20 PLN | -0.83% |
|
-1.48% | -11.75% |
| May. 27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| May. 15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 198.2 | +63.53% | 1 | ||||
| 56.55 | -4.98% | 11 | ||||||
| 21.14 | -7.67% | 7 | ||||||
| - | - | 48.3 | +29.25% | 1 | ||||
| 8.8 | +85.65% | 10 | ||||||
| 27.8 | -6.55% | 5 | ||||||
| 5.9 | -16.19% | 5 | ||||||
| - | 44,500 | +52.14% | 2 | |||||
| 8.333 | +72.89% | 3 | ||||||
| Average | 4,986.11 | +29.78% | 5 | ||||||
| Weighted average by Cap. | 2,463.44 | +13.99% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
